9 Months on Fin/Min Spray – Slow Progress, but some hope Progress Pictures 7/31/2025
The user has been using a Hims 4-in-1 spray with finasteride and minoxidil daily for 9 months, along with microneedling and red light therapy, and is considering trying new hair serums. Progress is slow, but there is hope for hair regrowth.
View this post in the Community →
Similar Community Posts Join
5 / 5 resultscommunity I use the big 4 to combat but I need to do more
The conversation discusses various hair loss treatments, including Minoxidil, Finasteride, Dutasteride, Ketoconazole shampoo, microneedling, and supplements like collagen, biotin, and vitamins. Users suggest additional treatments like red light therapy, scalp massages, and possibly adding RU58841 or Tretinoin.
community Progress in 10 months for 25 yo (my plan)
A 25-year-old shared their 10-month hair loss treatment progress using dutasteride, minoxidil, microneedling, red light therapy, Nizoral shampoo, and a hair oil. They experienced mild side effects with finasteride but none with dutasteride, and noticed significant improvement with the new regimen.
community Nice product I discovered, thought I would share.
A product that makes hair look thicker and healthier without promoting regrowth. Discussions include treatments like minoxidil, finasteride, red light therapy, and a serum with caffeine and peptides, with mixed effectiveness opinions.
community Topical Fin & Min, 5 Month Progress
Significant hair regrowth was achieved using a topical combination of 0.3% finasteride and 6% minoxidil, with weekly dermastamping and ketoconazole shampoo, without side effects. Others suggested additional treatments like red light therapy and PRP.
community Rate my Hair loss prevention stack
The user is using a comprehensive hair loss prevention regimen including Dutasteride, RU58841, topical treatments, red light therapy, microneedling, and supplements like Nutrafol, while avoiding Minoxidil. They also supplement with vitamin D and zinc and plan to start testosterone replacement therapy (TRT) in January.
Related Research
6 / 6 resultsresearch Platelet-rich plasma in androgenetic alopecia
This expert group provided recommendations for preparing and using platelet-rich plasma in treating androgenetic alopecia, suggesting a manual double-spin method and specific dosing, although further studies on injectable platelet-rich fibrin are needed.
research Female pattern hair loss—An update
This article discusses the causes, diagnosis, and treatment options for female pattern hair loss, emphasizing the role of topical minoxidil as a primary treatment, but provides no new clinical results.
research The rise of transcutaneous drug delivery for the management of alopecia: a review of existing literature and an eye towards the future
This study reviewed eight studies investigating transcutaneous drug delivery via fractional laser and microneedling for alopecia treatment, with six studies showing improved hair regrowth over topical therapy alone, suggesting its potential as a promising treatment strategy, although further research is needed to refine treatment parameters.
research Microneedle-Mediated Transdermal Drug Delivery for the Treatment of Multiple Skin Diseases
This study highlights the clinical potential of microneedles as an innovative transdermal drug delivery system for treating various skin diseases with minimal pain and high patient compliance.
research Beard Alopecia: An Updated and Comprehensive Review of Etiologies, Presentation and Treatment
This review provides a detailed overview of the causes, prevalence, pathophysiology, clinical presentation, and treatment of beard alopecia, highlighting conditions such as alopecia areata, pseudofolliculitis barbae, and tinea barbae, and aims to serve as a resource for clinicians handling such cases.
research Potential application of PBM use in hair follicle organoid culture for the treatment of androgenic alopecia
This article discusses photobiomodulation as a potential adjunct to hair follicle organoid culture for androgenic alopecia, reporting no new results and suggesting further study is needed.